Overnutrition Stimulates Intestinal Epithelium Proliferation Through β-catenin Signaling in Obese Mice
Overview
Authors
Affiliations
Obesity is a major risk factor for type 2 diabetes and cardiovascular diseases. And overnutrition is a leading cause of obesity. After most nutrients are ingested, they are absorbed in the small intestine. Signals from β-catenin are essential to maintain development of the small intestine and homeostasis. In this study, we used a hyperphagia db/db obese mouse model and a high-fat diet (HFD)-induced obesity mouse model to investigate the effects of overnutrition on intestinal function and β-catenin signaling. The β-catenin protein was upregulated along with inactivation of glycogen synthase kinase (GSK)-3β in the intestines of both db/db and HFD mice. Proliferation of intestinal epithelial stem cells, villi length, nutrient absorption, and body weight also increased in both models. These changes were reversed by caloric restriction in db/db mice and by β-catenin inhibitor JW55 (a small molecule that increases β-catenin degradation) in HFD mice. Parallel, in vitro experiments showed that β-catenin accumulation and cell proliferation stimulated by glucose were blocked by the β-catenin inhibitor FH535. And the GSK-3 inhibitor CHIR98014 in an intestinal epithelial cell line increased β-catenin accumulation and cyclin D1 expression. These results suggested that, besides contribution to intestinal development and homeostasis, GSK-3β/β-catenin signaling plays a central role in intestinal morphological and functional changes in response to overnutrition. Manipulating the GSK-3β/β-catenin signaling pathway in intestinal epithelium might become a therapeutic intervention for obesity induced by overnutrition.
Reduction of intestinal RIPK1 ameliorates HFD-induced metabolic disorders in female mice.
Yuan Y, Hu X, Guo C, Xu Y, Li S, Wen W iScience. 2025; 28(2):111906.
PMID: 40028283 PMC: 11869535. DOI: 10.1016/j.isci.2025.111906.
Dietary and metabolic effects on intestinal stem cells in health and disease.
Shay J, Yilmaz O Nat Rev Gastroenterol Hepatol. 2024; 22(1):23-38.
PMID: 39358589 DOI: 10.1038/s41575-024-00980-7.
Ho J, Puoplo N, Pokharel N, Hirdaramani A, Hanyaloglu A, Cheng C Front Genet. 2024; 15:1349717.
PMID: 39280096 PMC: 11393785. DOI: 10.3389/fgene.2024.1349717.
Wu H, Mu C, Li X, Fan W, Shen L, Zhu W Adv Sci (Weinh). 2024; 11(33):e2400058.
PMID: 38937989 PMC: 11434115. DOI: 10.1002/advs.202400058.
Hernandez-Martin M, Garcimartin A, Bocanegra A, Redondo-Castillejo R, Quevedo-Torremocha C, Macho-Gonzalez A Foods. 2024; 13(12).
PMID: 38928736 PMC: 11203255. DOI: 10.3390/foods13121794.